Noncolorectal Gastrointestinal Cancer Journal Articles

• Diagnosis and Treatment of Pancreatic Exocrine Insufficiency Pancreatic exocrine insufficiency is a frequent but often undertreated complication of pancreatic diseases and extrapancreatic conditions. Review its diagnosis and management in this brief primer.
  Current Opinion in Gastroenterology, August 2018
• Timing of HCV Therapy in Liver Transplant-Eligible Patients The authors developed a decision tree model to compare the cost-effectiveness of three strategies for timing of DAA treatment for HCV in liver transplant candidates.
  Journal of Viral Hepatitis, August 2018
• The Prevention of HBV-Related Hepatocellular Carcinoma This article discusses risk stratification of HBV-related hepatocellular carcinoma and summarizes three levels of preventive strategies.
  Alimentary Pharmacology & Therapeutics, August 2018
• HBV Reactivation in HBV/HCV Co-infection Treated With DAAs This study explored the outcome of HBV infection in patients co-infected with HBV and HCV and treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin.
  Journal of Viral Hepatitis, August 2018
• PPI and H2 Receptor Antagonist Use and Risk of Liver Cancer Do PPIs and H2 receptor antagonists contribute to the risk of primary liver cancer?
  Alimentary Pharmacology & Therapeutics, August 2018
• Risk Factors for Advanced Fibrosis After SVR in Chronic HCV This study investigated the long-term effect of achieved SVR on liver fibrosis in a cohort with pretreatment advanced chronic HCV infection. What risk factors are associated with persisting fibrosis?
  Journal of Viral Hepatitis, July 2018
• The Emerging Role of Oncolytic Virus Therapy Against Cancer Review the latest on oncolytic virotherapy and viruses currently in clinical testing.
  Chinese Clinical Oncology, July 2018
• Efficacy of Generic Oral DAAs in Patients With HCV Infection Are generic oral direct-acting antivirals as effective against HCV as branded drugs in a real-life clinical situation?
  Journal of Viral Hepatitis, July 2018
• HCV Eradication by DAAs Improves Glucose Tolerance Chronic HCV genotype 1 is associated with a higher incidence of type 2 diabetes in its advanced stages. Could early HCV eradication improve glucose tolerance in patients with HCV-related cirrhosis?
  Liver International, July 2018
• Real-world Use of Elbasvir-Grazoprevir in Chronic HCV This retrospective analysis evaluated outcomes of hepatitis C patients treated with elbasvir-grazoprevir with or without ribavirin in clinical practice settings in the United States.
  Alimentary Pharmacology & Therapeutics, July 2018
• Survival in Pancreatic Cancer With Germline Mutations Platinum-based therapy may improve survival in pancreatic ductal adenocarcinoma carrying deleterious germline mutations.
  JCO Precision Oncology, July 2018
• Reflex Testing for Germline Mutations in Pancreatic Cancer Ancestries are important when considering reflex founder mutation testing in patients with pancreatic cancer.
  JCO Precision Oncology, July 2018
• Latest Evidence for Particle Therapy in NSCLC What is the latest evidence on proton therapy for locally advanced lung cancer?
  Translational Lung Cancer Research, June 2018
• Adolescent Substance Use: Implications for Cancer Prevention This study statistically ranked states' performance on adolescent substance use related to cancer risk: cigarette smoking, binge alcohol drinking, and marijuana use.
  Preventing Chronic Disease, June 2018
• The Non-neuronal and Nonmuscular Effects of Botulinum Toxin New research suggests that botulinum neurotoxins may have a much wider range of both dermatological and nondermatological applications than originally thought.
  The British Journal of Dermatology, June 2018
• Hepatotoxicity of Immune Checkpoint Inhibitors Immune checkpoint inhibitors have proven utility as a new class of anticancer drugs, but carry with them the risk of hepatotoxic and other immune-related adverse events.
  Liver International, June 2018
• DAAs for HCV Infection and Risk of Incident Liver Cancer Does DAA-based HCV treatment reduce the risk of incident liver cancer compared to untreated HCV or interferon-based treatment?
  Alimentary Pharmacology & Therapeutics, June 2018
• Medical Marijuana Use in Older Adults When is medical marijuana appropriate for use in older adults? This article reviews the evidence regarding indications for and risks of medical marijuana in this population.
  Journal of the American Geriatrics Society, June 2018
• Text Messaging Approach Improves Weight Loss in NAFLD This study evaluated the efficacy of a text messaging intervention to improve weight loss and disease management in patients with NAFLD.
  Liver International, June 2018
• Bariatric Surgery and Increased Risk of New-onset IBD This large case-based study found that patients with new onset IBD were significantly more likely to have a past history of bariatric surgery than matched controls.
  Alimentary Pharmacology & Therapeutics, June 2018